Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment

J Burgess, M Ferdousi, D Gosal, C Boon… - Oncology and …, 2021 - Springer
Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

NIR‐II responsive inorganic 2D nanomaterials for cancer photothermal therapy: recent advances and future challenges

D An, J Fu, B Zhang, N Xie, G Nie… - Advanced Functional …, 2021 - Wiley Online Library
Non‐invasive cancer photothermal therapy (PTT) is a promising replacement for traditional
cancer treatments. The second near‐infrared region induced PTT (NIR‐II PTT, 1000–1500 …

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update

CL Loprinzi, C Lacchetti, J Bleeker… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To update the ASCO guideline on the recommended prevention and treatment
approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in …

Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship

MB Lustberg, NM Kuderer, A Desai… - Nature Reviews …, 2023 - nature.com
Despite the importance of chemotherapy-associated adverse events in oncology practice
and the broad range of interventions available to mitigate them, limited systematic efforts …

[HTML][HTML] Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention …

B Jordan, A Margulies, F Cardoso, G Cavaletti… - Annals of …, 2020 - Elsevier
Central and especially peripheral neurotoxicities due to systemic antineoplastic therapy are
common and often dose-limiting side-effects. In patients with chemotherapy (ChT)-induced …

Chemotherapy-induced peripheral neuropathy: where are we now?

LA Colvin - Pain, 2019 - journals.lww.com
Chemotherapy-induced peripheral neuropathy (CIPN) is a major challenge, with increasing
impact as oncological treatments, using potentially neurotoxic chemotherapy, improve …

Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects

P Di Nardo, C Lisanti, M Garutti, S Buriolla… - Expert opinion on …, 2022 - Taylor & Francis
Introduction Neo/adjuvant therapy for early-stage breast cancer has become increasingly
common in the last few decades; as a consequence, the number of breast cancer survivors …

Post-TB health and wellbeing

R Nightingale, F Carlin, J Meghji… - … of Tuberculosis and …, 2023 - ingentaconnect.com
TB affects around 10.6 million people each year and there are now around 155 million TB
survivors. TB and its treatments can lead to permanently impaired health and wellbeing. In …

Molecular mechanisms of exercise contributing to tissue regeneration

J Chen, R Zhou, Y Feng, L Cheng - Signal Transduction and Targeted …, 2022 - nature.com
Physical activity has been known as an essential element to promote human health for
centuries. Thus, exercise intervention is encouraged to battle against sedentary lifestyle …

[HTML][HTML] Effect and feasibility of wearable physical activity trackers and pedometers for increasing physical activity and improving health outcomes in cancer survivors …

B Singh, EM Zopf, EJ Howden - Journal of Sport and Health Science, 2022 - Elsevier
Purpose This systematic review and meta-analysis aimed to evaluate the effect of wearable
devices for improving physical activity and health-related outcomes in cancer survivors …